A Phase Ib, Dose-Finding Study of Multiple Doses of Remimazolam (CNS 7056) in Volunteers Undergoing Colonoscopy
- 1 November 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesia & Analgesia
- Vol. 117 (5), 1093-1100
- https://doi.org/10.1213/ane.0b013e3182a705ae
Abstract
We performed the first multiple dose study of remimazolam designed to assess both the feasibility of maintaining suitable sedation during colonoscopy and reversing the sedative effects of remimazolam with flumazenil. Healthy volunteers received fentanyl followed by remimazolam for sedation during colonoscopy. Three dose groups of 15 volunteers each received remimazolam in increasing initial doses, plus top-up doses to maintain sedation for a 30-minute period. In a separate double-blind crossover part of the trial, 6 volunteers were sedated with a single high dose of remimazolam, followed by flumazenil or placebo to reverse the sedation. Successful sedation that was adequate for colonoscopy was achieved in >70% of subjects. After the procedure, subjects rapidly recovered to fully alert, with a median of <10 minutes overall. Failures were due to the inability to sedate or adverse events, with 1 subject failing due to hypotension (arterial blood pressure 80/40) and low SpO2 (<90%). There were no serious adverse events reported, and no events that were unexpected with the combination of a benzodiazepine and fentanyl. The study also showed that sedation was rapidly reversible (1.0 minutes flumazenil vs 10.5 minutes placebo) without resedation. Remimazolam has the attributes of a sedative drug, with success rates comparable with recent studies of other drugs. Remimazolam provided adequate sedation in 33 of 44 subjects undergoing colonoscopy, and its sedative effects were easily reversed with flumazenil.Keywords
This publication has 9 references indexed in Scilit:
- A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056)Anesthesia & Analgesia, 2012
- A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic proceduresGastrointestinal Endoscopy, 2008
- CNS 7056Anesthesiology, 2007
- Research Advances in Procedural Sedation and AnalgesiaAnnals of Emergency Medicine, 2007
- Randomized Clinical Trial of Etomidate Versus Propofol for Procedural Sedation in the Emergency DepartmentAnnals of Emergency Medicine, 2007
- Endoscopic Sedation in the United States: Results from a Nationwide SurveyThe American Journal of Gastroenterology, 2006
- The Dawning of a New Sedative: Propofol in Gastrointestinal EndoscopyDigestion, 2004
- Modificationsto the postanesthesia score for use in ambulatory surgeryJournal of PeriAnesthesia Nursing, 1998
- Validity and Reliability of the Observer??sJournal of Clinical Psychopharmacology, 1990